Leniolisib for Immune Dysregulation in PIDs
Clinical trial NCT06549114 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06549114
- Sponsor
- Pharming Technologies B.V.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-21
- Primary completion
- 2026-11-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.